Spironolactone for Heart Failure with Preserved Ejection FractionBertram Pitt, Sonja M. McKinlay|New England Journal of Medicine|2014Cited by 2.7k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) TrialMarc A. Pfeffer, Bertram Pitt, Jerome L. Fleg et al.|Circulation|2014Cited by 1k
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D. Solomon, Marc A. Pfeffer, Brian Claggett et al.|European Heart Journal|2015Cited by 524
Direct relationship of antepartum glucose control and fetal erythropoietin in human Type 1 (insulin-dependent) diabetic pregnancyJohn A. Widness, Ray Schwartz, Gisela K. Clemons et al.|Diabetologia|1990Cited by 84